Tendinopathy Pipeline Insight 2025 | Breakthrough in Tendon Pain: Over 5 Pipeline Drugs in Development Unveiled [Yahoo! Finance]
MiMedx Group, Inc (MDXG)
Last mimedx group, inc earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=213465&p=irol-irhome
Company Research
Source: Yahoo! Finance
Covering drug profiles, therapeutic assessments, clinical trials, and regulatory activities, this report offers insights on emerging therapies and market challenges, focusing on key players like Causeway Therapeutics and drugs such as TenoMiR. Explore novel technologies, industry collaborations, and development stages, enhancing discovery in Tendinopathy management. Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Tendinopathy - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report provides a comprehensive overview of over five companies and pipeline drugs targeting Tendinopathy. This thorough examination includes both clinical and nonclinical stage products, offering insights into the therapeutic assessment based on product type, stage, route of administration, and molecule type. Additionally, inactive pipeline products in this sector are highlighted, providing a broad spectrum of current and future possibilities. Tendinopathy is a prevalent m
Show less
Read more
Impact Snapshot
Event Time:
MDXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDXG alerts
High impacting MiMedx Group, Inc news events
Weekly update
A roundup of the hottest topics
MDXG
News
- MiMedx Group, Inc. (NASDAQ: MDXG) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.MarketBeat
- Spectral AI Announces Appointment of Stanley Micek as Chief Operating Officer [Yahoo! Finance]Yahoo! Finance
- MIMEDX to Participate in Upcoming Investor ConferencesGlobeNewswire
- Insiders Pour $1 Million Each into These 2 ‘Strong Buy' Stocks? – Here's Why You Might Want to Follow Their Lead [Yahoo! Finance]Yahoo! Finance
- MiMedx Group, Inc. (NASDAQ: MDXG) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
MDXG
Earnings
- 4/30/25 - In-Line
MDXG
Sec Filings
- 7/7/25 - Form 4
- 6/26/25 - Form 4
- 6/23/25 - Form 4
- MDXG's page on the SEC website